CureVac Starts Phase 1 Clinical Study of Modified, Omicron-Targeting COVID-19 Vaccine Candidate

Phase 1 dose-escalation study to be conducted at clinical sites in the U.S., the UK, Australia, and the PhilippinesMilestone demonstrates CureVac's continued execution on comprehensive clinical program of second-generation vaccine candidates for …